Description and Brand Names
Drug information provided by: Merative, Micromedex®
US Brand Name
Mirvetuximab soravtansine-gynx injection is used to treat folate receptor-alpha (FRa) positive platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who have received 1 to 3 previous treatments. Your doctor will perform a test to check for the FRa tumor before you receive this medicine.
This medicine is to be given only by or under the immediate supervision of your doctor.
This product is available in the following dosage forms: